Search
for
Sort by
Research 301–330 of 888
- 874 Chromatin architectural protein CTCF controls epidermal barrier formation, hair follicle fate maintenance and suppresses inflammatory responses in the skin epithelium
- 876 Manipulation of stem cell divisional behavior: Selectively promoting asymmetric and symmetric keratinocyte divisions in vitro
- An immune regulatory CCT repeat containing oligodeoxynucleotide capable of causing hair loss in male mice
- Diagnosis and treatment of alopecia areata
- Alopecia Areata
- Vaccines, Infections, and Alopecia Areata
- Hair, Cutaneous Homeostasis and Stem Cell Functions
- Recalcitrant widespread alopecia areata in a child treated successfully with oral methylprednisolone pulse therapy
- Neurosteroids on the Epilepsy Chessboard—Keeping Seizures in Check
- Alopecia
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- Abstracts
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Steroid sulfatase inhibitors
- The Role of Histone Demethylases in Disease
- Total Glucosides of Paeony Capsule Plus Compound Glycyrrhizin Tablets for the Treatment of Severe Alopecia Areata in Children: A Randomized Controlled Trial
- 004 Cell-based therapy may be effective in alopecia areata: Preclinical evidence that autologous, peripheral regulatory γdT cells are preventive in human ex vivo and therapeutic in human in vivo models
- A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
- Endogenous Retinoids in the Pathogenesis of Alopecia Areata
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- Dermal lymphatic dilation in a mouse model of alopecia areata
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Alopecia areata in a composite tissue (hand) allograft recipient following graft rejection
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- 0054 Treg-targeted therapies restrain disease in a murine model of alopecia areata
- Epidermal γδ T cells, CD8 T cells and macrophages are increased in number in alopecia areata and express BST2 as part of an interferon-driven antiviral gene signature
- 229 Single cell transcriptomics identifies a potential role for Arg1+ macrophages in alopecia areata pathogenesis
- 526 Gut dysbiosis in alopecia areata patients reveals overabundance of firmicutes and under representation of bacteroides
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition